Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
seqWell Appoints New Commercial Team, Led by Chief Commercial Officer Steve Smith
seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing […]
Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer
Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering RNA cell therapy in and beyond […]
Prime Therapeutics Welcomes Chris Knibb as Chief Financial Officer
Chris Knibb, an accomplished finance executive with more than 25 years of financial and business […]
Vividion Therapeutics Announces Formation of Scientific Advisory Board
Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally […]
LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director
LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]
Steven Penn Joins Care Angel as Chief Financial Officer/Chief Operations Officer
Care Angel, the leader in AI and voice-enabled nurse assistant technology, today announced that Steven Penn has joined […]
Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
Sutro Biopharma Announces Expansion of Leadership Team
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on […]
Respiratory Monitoring Medtech Firm Appoints Global Expert Dr. Peter Small as Chief Medical Officer
Fast-growing AI Medtech company Hyfe has, today, announced the appointment of world-renowned Seattle-based physician and […]
Anocca Appoints Jacob Michlewicz as CFO
Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more